Mutual of America Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$282K Sell
2,479
-273
-10% -$31K ﹤0.01% 1224
2025
Q1
$289K Sell
2,752
-110
-4% -$11.6K ﹤0.01% 1247
2024
Q4
$307K Buy
2,862
+115
+4% +$12.3K ﹤0.01% 1273
2024
Q3
$275K Sell
2,747
-29
-1% -$2.9K ﹤0.01% 1312
2024
Q2
$234K Sell
2,776
-48
-2% -$4.04K ﹤0.01% 1358
2024
Q1
$206K Sell
2,824
-45
-2% -$3.29K ﹤0.01% 1409
2023
Q4
$205K Buy
+2,869
New +$205K ﹤0.01% 1407
2023
Q3
Sell
-3,206
Closed -$231K 1467
2023
Q2
$231K Sell
3,206
-98
-3% -$7.07K ﹤0.01% 1369
2023
Q1
$243K Sell
3,304
-60
-2% -$4.41K ﹤0.01% 1340
2022
Q4
$225K Sell
3,364
-1,751
-34% -$117K ﹤0.01% 1362
2022
Q3
$275K Buy
5,115
+575
+13% +$30.9K ﹤0.01% 1263
2022
Q2
$253K Buy
4,540
+682
+18% +$38K ﹤0.01% 1252
2022
Q1
$271K Buy
3,858
+197
+5% +$13.8K ﹤0.01% 1253
2021
Q4
$353K Buy
3,661
+96
+3% +$9.26K ﹤0.01% 1195
2021
Q3
$310K Sell
3,565
-19,900
-85% -$1.73M ﹤0.01% 1217
2021
Q2
$1.92M Sell
23,465
-319
-1% -$26.1K 0.02% 982
2021
Q1
$2.26M Sell
23,784
-540
-2% -$51.4K 0.02% 912
2020
Q4
$1.51M Buy
24,324
+90
+0.4% +$5.58K 0.02% 999
2020
Q3
$1.44M Buy
24,234
+319
+1% +$19K 0.02% 952
2020
Q2
$1.67M Sell
23,915
-661
-3% -$46.1K 0.02% 901
2020
Q1
$1.12M Sell
24,576
-1,255
-5% -$56.9K 0.02% 950
2019
Q4
$1.68M Sell
25,831
-1,399
-5% -$91K 0.02% 979
2019
Q3
$1.69M Sell
27,230
-564
-2% -$35K 0.02% 926
2019
Q2
$1.98M Sell
27,794
-1,010
-4% -$71.9K 0.03% 880
2019
Q1
$2.26M Sell
28,804
-1,331
-4% -$104K 0.03% 815
2018
Q4
$2.55M Buy
30,135
+29,492
+4,587% +$2.5M 0.04% 677
2018
Q3
$110K Buy
643
+518
+414% +$88.6K ﹤0.01% 1171
2018
Q2
$16K Buy
+125
New +$16K ﹤0.01% 1216
2014
Q3
Sell
-641
Closed -$25K 1262
2014
Q2
$25K Buy
+641
New +$25K ﹤0.01% 1247